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Abstract: Even though antibiotics are necessary in livestock production, they can be harmful not only
due to their toxicity, but also in view of their contribution to the emergence of antimicrobial resistance.
Screening tests based on microbial growth inhibition appeared to be useful tools to prevent its entry
into the food chain. They have nevertheless been traditionally carried out post mortem, leading to
great economical loss and harm to the environment in case a positive sample is found. Hence, the
objective was to evaluate the use of a screening test as an ante mortem alternative for the detection of
antibiotic residues in meat: thus, Explorer®-Blood test was optimized and validated. After adapting
the procedure for matrix preparation, the assay parameters were assessed from 344 antibiotic-free
blood serum samples. Limits of Detection (LoDs) were defined by spiking blood serum with several
of the most common antimicrobials used in veterinary practice. LoDs were similar to those obtained
for meat and were at or below the maximum residue limits set by EU legislation for muscle. Analyses
of in vivo injected samples, previously characterized by LC-MS/MS, demonstrated the method’s
accuracy and proved that Explorer®-Blood can be considered a suitable alternative to conventional
post mortem screening methods.
Keywords: antibiotics; sulfonamides; antimicrobials; blood; in vivo; biological test
1. Introduction
Antimicrobial detection tests are conventional screening tools used in slaughterhouses
to prevent the entry of antimicrobial residues into the food chain. The occasional ap-
pearance of antibiotic or bacteriostatic residues is a problem of major worldwide concern,
as such residues can lead not only to toxicity for humans, but also to the emergence of
antimicrobial resistance (AMR) [1,2]. In particular, antibacterial residues that contaminate
meat can cause allergic reactions, can lead to dysbiosis of the gastrointestinal flora and
can enhance dissemination of AMR, not only in the environment but also inside the gut,
leading to antibacterially resistant communities in our intestinal flora [3–6]. Even though
the development of AMR is the most critical issue as it is responsible for the loss of effec-
tiveness of antimicrobials against common infectious diseases, less studied aspects, such as
the unknown toxicity of their derivates after cooking meat [7] or the presence of residues
of oxidative antimicrobials that disrupt the endogenous antioxidant system [8], should
likewise be taken into consideration.
In order to address this problem and create a safe environment for consumers, the
European Union (EU) has established an extensive legislative framework by restricting
the authorization of medicinal products allowed for veterinary use [9], by determining
maximum residue limits (MRLs) [10], by setting safe withdrawal periods [11], by monitor-
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ing plans [12] and by establishing a series of analytical methods for the testing of official
samples [13].
A wide range of methods for the analysis of antibiotic residues in meat are cur-
rently available. In Europe, methods for official control are classified as screening and
confirmatory methods. The most common surveillance programs for antibiotic residue
control start by screening a large number of samples in a short time with easy, inexpensive
methods [14]. Screening methods must detect a broad spectrum of antimicrobials at the
regulatory levels; ideally, no more than 5% false compliant results should be accepted.
Moreover, presumptive non-compliant results must be confirmed with a suitable validated
method [13].
Among recommended screening methods, several commercialized tests for the de-
tection of antibiotics in food matrices based on growth inhibition of microorganisms are
available. Many of them inhibit the growth of microorganisms such as Geobacillus stearother-
mophilus when antibacterial residues are present in a sample [14]. Further simplification
and automatization of this kind of assays has been proposed in recent years. An example
of such methods is the Explorer® test, initially validated for the analysis of muscle [15] and
eggs [16]. Explorer® tests are presented in a tube in which a specific detection media is
spread with the target microorganism. A growth indicator is additionally included in the
medium, usually based on change of pH or redox potential. When the target microorganism
grows (thereby indicating that the sample contains no antibiotics, or that their residues lie
below the method’s limit of detection), the test medium colour changes from blue/purple
to yellow/orange. However, if the sample contains antimicrobials, metabolism of the
bacteria is stopped or slowed down and no colour change or only a partial colour change
is visible.
Surveillance of antibiotic residues in foods of animal origin is carried out post mortem.
If a positive sample is found to have amounts of antibacterial residues that are over the
limits set by legislation (MRLs), carcasses must be confiscated and destroyed. Such an
event has devastating repercussions for the farmer, who has to face substantial financial
loss caused by severe fines, as well as the investment lost in breeding animals of no value.
In addition, one must consider the harmful environmental impact of breeding livestock
that ends up as waste, associated with the misuse of input resources and the release
of contaminating output such as gas emissions, manure/slurry, residual water and the
challenge of destroying the carcasses [17].
The analysis of antimicrobial residues in animals prior to slaughter has thus been
attracting increased attention in recent years [18,19]. Several issues need to be solved,
however, before implementing a methodology for in vivo testing for antibiotics. First
of all, the selection of the most suitable matrix (tissue or biological fluid) is an essential
requirement. A matrix for antibiotic detection should be easy to collect and should be
representative of the level of antimicrobial substances found in edible tissues (e.g., muscle).
To ascertain this, several studies comparing the concentration of antibacterial compounds
in body tissues and fluids have been published [20–24]. A most recent study carried out
on pigs demonstrated that blood serum was the most suitable matrix for laying the bases
of a new in vivo antimicrobial detection test [25], as the concentration of antimicrobial
molecules in blood serum showed an acceptable equivalence with that found in muscle
(Figure 1b). Moreover, the collection of blood from living animals is a simple practice that
is commonly carried out in farms.
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Figure 1. Colour change kinetics registered by e-Reader® for positive (dark line) and negative (light line) blood serum
samples analysed with Explorer®-Blood test (a) and muscle samples analysed with Explorer® (b).
The implementation of systems for ante mortem screening of antibiotics in livestock
by testing blood serum samples could help to overcome the aforementioned limitations of
post-mortem analysis. In order to be put into practice as a routine plan, the method needs
to be rapid and affordable, allowing for decision-making within a few hours. However,
no simple and automatic method has yet been adapted for the screening of antimicrobials
in blood.
Therefore, the aim of this study was to optimize and validate Explorer®-Blood, based
on the utilization of the Explorer® test, as an ante mortem method for the detection of
antimicrobial residues in blood samples obtained from living animals, in order to prevent
their presence in carcasses and meat prior to their commercialization.
2. Materials and Methods
2.1. Blood Serum Samples
2.1.1. Antibiotic-Free Blood Serum Samples
A total of 344 blank blood samples coming from antibiotic-free farms of Zaragoza
province (Spain) were collected for the purpose of establishing the new method’s reading
parameters (cut-off and reading time) and false positive rate.
2.1.2. Antimicrobials Choice for Validation
Micr bial inhibition tests are regarded as ulti-class methods, that m ans they can
detect a broad spectrum of antimicrobial groups. The Explorer® test is capable of detecting
a wide range of over 50 antimicrobial substances. A complete validation, including all the
antimicrobials featuring an EU-MRL in muscle, would be unaffordable in terms of time
and expense [26]. In order to select a reasonable number of molecules to be included in
the validation, only representative molecules were taken into account. The criterion used
for that purpose was to select one or two molecules from each of the main antimicrobial
families. Molecules from each antimicrobial family were selected according to their poten-
tial frequency of use in livestock, specifically in pig farming. Thus, the antimicrobial drugs
authorized for use in pig farming in Spain were obtained from CIMAVET database [27].
The frequency distr butio of the antim crobial families included in the authorized drugs
list is shown in Figure 2. Tetracyclines, β-lactams and quinolones were present in half of
the authorized drugs.
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Figure 3. Number of approved products from the main authorized families for veterinary practice in
pig farming [27]. Black bars show the total number of approved molecules of the main antimicrobial
families, and white bars represent the number of those most frequently authorized: amoxicillin for ß-
lactam; oxytetracycline and doxycycline for tetracyclines; sulfadiazine for sulfonamides; lyncomicin
as the only molecule included in its family; neomycin and apramycin f r aminoglicosides; tylosin for
macro ides; ceftiofur for c falo porines and enrofloxacin for quin lones.
2.1.3. Antimicrobial Standards and Spiked Blood Serum Samples
Antibio ics (am xicillin, c phalexin, ceftiofur, oxytetracycli e, d ycycline, neomycin,
apramycin, tylosin and lincomycin) and sulfonamides (sulfamethazine and sulfadiazine)
used as standards were supplied by Sigma-Aldrich (Poole, UK). For each of them, a
stock solution of 1 mg mL−1 was made in water or methanol (depending on solubility
specifications given by the supplier), and aliquots were kept at −20 ◦C for no more than
2 months.
Spiked blood serum samples were used for the establishment of the limits of detection
(LoD). Working dilutions were freshly made on a daily basis. Standards were prepared
by spiking blank blood sera with the appropriate dilution to obtain the indicated levels
for each molecule (Table 1), using as a reference the EU-MRLs and the LoDs described
for muscle when tested with the Explorer® test [15]. No more than 10% of antimicrobial
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dilution was added to the blood serum sample in order to avoid significant changes in the
matrix composition.
Table 1. Antimicrobial substances and levels selected to determine the LoDs of Explorer® coupled to
e-Reader® for blood serum. The table additionally shows the EU-MRLs for muscle.
Molecule Concentration Level Tested(µg/L) MRL (Muscle)
Amoxicillin 10, 15, 20 50
Cefalexin 100, 200, 250, 300, 400 200
Ceftiofur 100, 200, 300, 400 1000
Sulfamethazine 100, 150, 200 100
Sulfadiazine 50, 100, 150 100
Oxitetracycline 100, 200, 300 100
Doxicyclin 100, 200, 300, 400 100
Neomycin 5, 15, 25, 50 500
Apramycin 500, 1000, 1500 1000
Tylosin 25, 50, 75 100
Lincomycin 200, 300, 400 100
2.1.4. Blood Samples with Antibiotics Injected In Vivo
Blood samples with antibiotics injected in vivo were obtained from the sample bank
built by Serrano et al. [25] from antibiotic-treated and untreated pigs. All the blood serum
samples were analysed by LC-MS/MS to determine the concentration of antibiotic residues
using a Waters Acquity Liquid Chromatograph (Waters Corporation, Milford, MA, USA).
These blood samples were used for the validation of the test once the LoDs were determined
with spiked samples.
2.2. Sample Preparation
As previously described, swine blood samples were obtained from the sample bank
and local farms. Whole blood, blood diluted in buffer and serum were initially tested
with Explorer® tubes to evaluate their suitability for antimicrobial analysis. To obtain
serum, after collection, blood was coagulated at room temperature for 1 h, following the
protocol established by Serrano et al. [25]. The coagulum was then removed, and serum
was centrifuged at 3000 rcf for 10 min on a Heraeus Megafuge 1.0 R centrifuge (Heraeus,
Hanau, Germany). Blood sera were stored at −20 ◦C until analysis.
In addition, several conditions for sample preparation were tested, bearing in mind
that the sample preparation process should be kept as simple as possible in order to be
performed at the farms or slaughterhouses where time and laboratory equipment are not
available. Blood dilution in PBS, serum obtention and additional thermal treatments to




Explorer® (Zeulab, S.L., Zaragoza, Spain), is a qualitative test supplied in an ampoule
format, based on the inhibition of microbial growth of G. stearothermophilus. Each tube test
contains a nutrient medium spread with the target bacteria and a pH indicator. When the
test is incubated at 65 ◦C, spores germinate and cells grow, thereby producing acid and
changing the medium colour from blue to yellowish. Colour changes are monitored by
an e-Reader® device (Zeulab, S.L., Zaragoza, Spain) as an indication of microorganism
metabolism. When the sample contains antimicrobials at levels higher than the LoD delays
in the acidification kinetics, no colour changes are observed and consequently, samples are
interpreted as positive.
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2.3.2. Procedure
100 µL of sample were added to an Explorer® test tube with a micropipette, and
then pre-incubated at room temperature for 20 min to allow sample diffusion through
the medium. Sample was subsequently discarded, and the tubes were washed once
with distilled water. Water excess was removed by turning the tubes upside down over
adsorbent paper. Finally, the tubes were incubated in the e-Reader® device at 65 ◦C. Results
were obtained after approximately 180 min.
2.4. Parameter Setting and Validation of the Explorer®-Blood Test
2.4.1. Cut-Off Level
To determine the optimal moment to halt the assay, kinetics of colour changes were
monitored for negative and positive samples along incubation time with the e-Reader®
device. To establish the cut-off level of the test, 344 blood serum samples from pigs grown in
antibiotic-free farming conditions were analysed, and Equation (1) was applied at different
incubation times.
Equation (1). Cut-off level of the Explorer®-Blood test.
Cut-off = x ± 3SD (1)
Samples displaying a result above the determined cut-off were considered positive.
2.4.2. Limits of Detection (LoD)
For practical reasons, LoDs were determined by spiking blood sera with chosen
antimicrobial substances at different levels. For the preparation of the spiked samples, at
least 2 different standard solutions were used for each substance. To calculate the LoD, each
antimicrobial was analysed at 3–4 levels around the EU-MRL [10] for muscle, and at a level
matching the LoD expected for that compound. When the test did not detect an expected
concentration as positive, a higher level was added to the study. Table 1 summarizes the
substances and levels tested in the study.
Since there are no specific guidelines for the validation of screening methods for the
detection of antibiotics in blood serum, a specific guideline for the validation and LoD
establishment of microbial inhibition tests for the detection of antibiotics in milk (ISO 13969:
2003) [28] was adapted. It indicates that when interpretation is performed with an objective
reading system, only 3–5 replicates are required for each substance/level combination.
Therefore, at least 3 replicates per concentration level (Supplementary Materials,
Table S1) were tested. The LoD was considered as the lowest level in which all repetitions
gave a positive result. However, to obtain a more reliable estimation, up to 8 replicates
were performed at the LoD level.
2.4.3. False Positive Rate
False positive rate was determined by testing 344 blood serum samples from pigs
grown in antibiotic-free farming conditions. Results above the established cut-off would
indicate a false-positive result and require additional confirmation.
2.4.4. Validation with Blood Samples Containing Antibiotics Injected In Vivo
Blood samples with different in-vivo-injected levels of oxytetracycline, sulfamethoxypyri-
dazine and amoxicillin were analysed with Explorer® test, and results were compared to
those obtained by LC-MS/MS as described by Serrano et al. [25].
2.5. Statistical Analysis
Results were obtained from at least 3 replicates and are presented as the mean ± standard
deviation. The PRISM® program was used for data processing and representation, as well
as for statistical analysis (GraphPad Software, Inc., San Diego, CA, USA).
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3. Results and Discussion
3.1. Matrix Preparation and Test Procedure
According to the results obtained by Serrano et al. [25], an acceptable equivalence ex-
ists between the concentration of antibiotics in blood and in muscle for all the antibacterial
compounds studied (oxytetracycline, sulfamethoxypyridazine, enrofloxacin and amoxi-
cillin), at a range of concentrations between the LoD and more than 4 (oxytetracycline)
and 40 (amoxicillin and sulfamethoxypyridaxine) times the EU-MRL. Hence, blood was
selected as the most suitable matrix for in vivo antimicrobial detection. Several commercial
tests are available on the market for the screening of antimicrobials in edible products, but
until now only the Explorer® test has been optimized to be performed with an automatic
system for reading and interpretation of results [15,16]. Therefore, due to its ease of use and
automatic interpretation, the Explorer® test was chosen to be adapted for the detection of
antimicrobials in blood. Its features make it suitable for use in farms and slaughterhouses,
where the time to obtain results is limited and laboratories are not readily available.
In a first step, blood was directly added to Explorer® tubes in order to evaluate its
behaviour. However, as this test is based on the colour change of the medium, blood
tonality modified the appearance of the test to the point of hindering interpretation of
results; and an additional step sample preparation was therefore required to ensure the
test’s accurate performance. Thus, several conditions for sample preparation were tested:
blood serum collection, blood dilution in buffers and additional thermal treatments to
deproteinize serum (data not shown) were evaluated. All the preparation methodologies
showed a similar improvement in acidification kinetics compared to the direct addition
of blood. Nevertheless, although blood dilution in buffer showed similar kinetics, a loss
in the test’s detection capability due to the dilution effect could be expected. Moreover,
blood serum is easy to obtain compared to methodologies for deproteneization, and the
acidification kinetics showed curve shapes (Figure 1a) similar to those obtained with meat
juice (Figure 1b), one of the usual matrices for which the Explorer® test and the e-Reader®
device were previously optimized. Thus, blood serum extraction was selected as the more
suitable sample preparation method, since it consequentially reduced time and workload
for the new Explorer®-Blood test.
3.2. Parameter Settings
Microbial inhibition tube tests are qualitative screening methods, which means that
they give binary results (positive or negative). Even though these kinds of tests are
ready to use and only require an incubator, they need to be halted at an adequate point
in time to avoid over- or under-incubation and, thus, to obtain best results in terms of
sensitivity. Moreover, a visual reading of results can lead to misinterpretation, as well as
discrepancies between lab results and those obtained by users [29]. To overcome these
issues, Mata et al. [15] proposed the automation of assays by coupling the microbial test
(Explorer®) with an automatic device (e-Reader®) designed to detect antimicrobials in
muscle. Automation was later extended to the detection of antimicrobials in milk [30,31]
and eggs [16]. This device includes a thermostatic incubator adapted to the test tubes,
and an optical system to monitor colour change. Both are integrated with a software that
controls device functions and automatically detects the end-time of the assay to provide an
objective result. Handling thereby becomes so easy that analysis can be performed at any
location (on a farm, or during lairage time at the slaughterhouse), even by untrained staff.
When an objective reading value is obtained through a reader device, it is necessary
to establish a cut-off level as a binary criterion for the interpretation of results. In addition,
setting the assay end-time is crucial in order to obtain best performance. To establish the
method’s assay end-time and cut-off, blank blood serum samples were assayed with the
Explorer®-Blood test and colour change kinetics were monitored along the incubation
time with e-Reader®. Figure 1a shows the kinetics of a blank blood serum sample (free of
antimicrobials) and the kinetics of a sample containing antimicrobials at concentrations
lying over the test’s LoD. Kinetics described for the blank sample showed a typical sigmoid
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curve corresponding to the acidification of the medium as a consequence of the target
microorganism growth when antimicrobials are not present in the sample. The highest
e-Reader® values (around 140 units) were obtained at the beginning of the assay, when
colour was blue-purple, and the lowest (around 25 units) when colour shifted to yellow.
Samples containing antibiotics at concentrations lying over the LoD were not able to reach
a complete acidification during the assay; therefore, the kinetics could not reach the lowest
values (or they were reached after a considerable delay).
3.2.1. End-Time
The end-time of the assay was established after having studied the kinetics of 8 blank
blood sera: it is the moment when the test must be stopped and results can be read. After
having evaluated the curves, it was decided to conclude the assay when e-Reader® results
reached a value of 35, corresponding with the value at which the kinetics start to slow
down the slope. It is the moment when the optimal relationship between the assay’s
highest sensitivity and the lowest variability is achieved. If the test is halted too soon (i.e.,
under-incubation), a higher sensitivity can be obtained, but the assay’s overall variability
increases. To exemplify this increase in variability, 8 blank serum samples were analysed
with Explorer®-Blood: the standard deviation (SD) obtained for e-Reader® values was 5.0
when the assay was halted at a mean value of 35. However, SD increased up to 8.8 when the
assay was concluded at a mean value of 50, indicating an increase in variability associated
with a shorter assay time. Consequently, if the assay was under-incubated, the need arose
to set a higher cut-off value in order to reliably obtain positive results while compensating
for the increase in readout variability and reducing the false-positive rate [19]. Conversely,
with longer incubation times, variability was reduced (SD = 1.7 when the assay was halted
at a mean value of 25). Consequently, the test’s sensitivity was also reduced, particularly in
the case of bacteriostatic molecules, thereby increasing the risk of obtaining false-negative
results. This shows that detection capability decreases when the incubation time is too
long. However, as the endpoint of the test is based on the optical measure of the negative
control and does not depend on a previously defined time extent, this issue does not affect
the assay’s precision [29].
3.2.2. Cut-Off Level
Once the assay end-time was established, it was necessary to calculate the point
in time at which samples are considered positive: the cut-off level. The cut-off of a
screening test is the response or signal which indicates that a sample contains an analyte
at or above the target concentration, thereby ensuring discrimination between positive
and negative samples. In order to establish the cut-off of the assay, a total number of
344 serum samples were analysed. The e-Reader® values for each one of those samples at
the point in time when the negative control reached the assay end-time are represented
in Figure 4. An average value of 36 was obtained, and SD was around 6. By applying
a safety factor of 3 times the SD (for a 99.7% level of confidence) and rounding up, the
cut-off value was established at 55, signifying that all samples with colour values over 55
are considered positive.
The cut-off depends on the method’s desired safety level. When the aim is to avoid
assigning any non-compliant sample as negative, the established cut-off has to be reliable,
but as low as possible. This criterion is proposed by the CRL (Community Reference
Laboratories Residues) [32] guidelines for the validation of screening methods to be used
in official controls (safety factor = 1.64 times the standard deviation from the average value
of negative samples). In this case, the method’s sensitivity increases, but the false-positive
rate can also rise, which means that true negative samples could be assigned as positive.
Such a situation would require further confirmatory analyses, and the total cost and time
of analysis would consequently increase. On the other hand, when a low number of false
non-compliant results is required, for instance due to difficulties in the implementation
of a confirmatory method, the cut-off level can be set higher (to obtain a higher level of
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confidence when assigning positive results). In this case the false-positive rate would
decrease, but detection capability might be compromised due to the detection of certain
antibiotics. Hence, it is important to find the right balance according to one’s intended
purpose. In the present study, it has been selected a high level of confidence (safety factor =
3 times the standard deviation from the average value of negative samples), since this test is
destined to be used at farm level or in stages prior to slaughter where reliable confirmatory
methods are not available.
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3.2.3. False Positive Rate
After the establishment of the test’s end-time and cut-off level, the results obtained
after analysing the 344 blank blood sera were studied. None of the blank samples yielded
a positive result (Figure 4). Therefore, a 0% false positive rate was described for the
new method.
3.3. Limits of Det ction (LoDs) in Swine Blo Serum
Once the testing procedure and the cut-off criteria are established, one must assess
whether the test’s limits of detection are fit-for-purpose. Ideally, for in vivo screening,
LoDs should be equal to or lower than those obtained in muscle to prevent delivering
positive animals to slaughterhouses. LoD was established as the lowest level at which all
samples gave a positive result. According to ISO 13969:2003, at least 3–5 replicates for each
substance/level combination need to be performed. To set the LoD in the present study, at
least 8 spiked samples at the level of interest were tested (Table S1).
Table 2 summarizes the LoD for swine blood serum obtained fr m those analyses with
Explorer®-Blood test coupled to -Read r®. In general, the e-Rea r® values obtained for
th tested a timicrobi ls we e far r moved from the cut-off level (set to 55 units), which
indicat s hat the system is thoroughly reliable n distinguishing positive from negative
sampl s, and that the LoD for certain molecules could be set even lower. The corresponding
LoD for muscle was also included for comparison. As MRLs have not been established
for blood, those est blished by EU legislation for muscle were used as a reference. A
satisfactory equivalence has been found between antibacterial concentration in muscle
and blood serum for some antimicrobials (oxytetracycline and enrofloxacin), but not for
others (sulfamethoxypyridazine), which correlated well but had higher concentrations in
blood than in muscle [25]. Moreover, data from the validation of the Explorer®-Blood test
showed a LoD for sulfonamides equivalent to the LoD obtained when applying Explorer®
to meat [15]. Even though a false positive could appear due to a higher concentration of
sulfonamides in blood compared to muscle, this should not be regarded as a concern that
would affect consumer safety.
Foods 2021, 10, 1897 10 of 14
Table 2. Limits of detection (LoD) of Explorer®-Blood test coupled to e-Reader® obtained for several
molecules from different families of antibacterial compounds in blood serum. LoD for muscle
(Mata et al., 2014) and the corresponding MRL (Commission Regulation (EU) No. 37/2010)) are also
included for comparison. e-Reader® values are presented as the mean ± standard deviation (SD) of
at least 8 independent replicates. LoD and MRL are presented as µg Kg−1.
Molecule e-Reader® Value LoD Serum LoD Muscle MRL (Muscle)
Amoxicillin 121 ± 7 10 10 50
Cefalexin 67 ± 5 200–250 200 200
Ceftiofur 103 ± 9 300 200 1000
Sulfamethazine 76 ± 7 100 100 100
Sulfadiazine 89 ± 4 100 50 100
Oxitetracycline 80 ± 6 200 200 100
Doxicyclin 80 ± 7 100 100 100
Neomycin 99 ± 6 25 ≤200 500
Apramycin 123 ± 4 ≤500 900 1000
Tylosin 92 ± 3 25–50 100 100
Lincomycin 65 ± 3 200 300 100
3.4. Validation with Blood Samples Injected In Vivo
Beyond the LoDs established with spiked samples, the method’s performance was
assessed with serum samples injected in vivo, containing residues of amoxicillin, oxyte-
tracycline and sulfamethoxypyridazine. Samples with levels of amoxicillin below the
LoD of the confirmatory method gave negative results with Explorer®-Blood (Table 3).
Conversely, samples with higher levels of amoxicillin gave positive results. However,
2 samples with initial levels of 58 and 73 ppb as determined by LC-MS/MS were negative
to Explorer®-Blood analysis. This result was unexpected, since the LoD for amoxicillin
with Explorer®-Blood is much lower (10–15 ppb), and it is coherent with the LoDs found
previously for muscle [15]. Therefore, these samples were re-analysed with LC-MS/MS in
order to verify any degradation of antibiotics, as they had been kept frozen for 18 months
before the analyses with Explorer®-Blood were performed. Confirmatory analysis demon-
strated that amoxicillin residues had been degraded, as amoxicillin was no longer detected
by LC-MS/MS. To our knowledge, no study of the stability of antibiotics in blood serum
has been previously reported. However, the stability of antibiotics in meat can indeed
be low in some cases [7,33,34] and could thus compromise confirmatory analysis results.
Confirmation of presumptive positive results should therefore be carried out as soon as
possible after screening, as certain storage conditions such as freezing temperature, time of
storing and sample preparation may have an impact on antimicrobial stability [33].
Table 4 shows the results obtained for oxytetracycline: samples with high levels were
adequately detected by Explorer®-Blood. Even some samples with oxytetracycline levels
around the EU-MRL value for muscle could be detected (71 and 102 ppb), while others
could not (83 and 89 ppb). These results are consistent with the LoD determined for
Explorer®-Blood by spiking antibiotic-free sera with oxytetracycline, where only half of
the replicates were positive at 100 ppb, while 100% of replicates gave positive results at
200 ppb.
In the case of sulfamethoxypyridazine, positive results were found even below 50 ppb
(Table 5). This molecule was not included in the spiking study previously described;
the result is nevertheless consistent with the LoD for other sulfonamides included in
the validation study, where they were detected at 100 ppb (100% of replicates), thereby
indicating that some positive replicates could be obtained at lower levels.
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Table 3. Explorer®-Blood test coupled to e-Reader® values obtained for blood serum samples injected
in vivo with amoxicillin and analysed by LC-MS/MS. The qualitative positive (+)/negative (−) result
is also shown in the table. Cut-off = 55.
Sample LC-MS/MS (µg Kg−1) e-Reader® Value Qualitative Result
1 <10 45 −
2 <10 47 −
3 73/ND * 41 −
4 <10 45 −
5 <10 48 −
6 <10 37 −
7 58/ND * 36 −
8 <10 37 −
9 <10 39 −
10 262 129 +
11 2005 121 +
12 872 126 +
13 1484 121 +
* ND: non detected by LC-MS/MS at the time the samples were analysed with Explorer® Blood.
Table 4. Explorer®-Blood test coupled to e-Reader® values obtained for blood serum samples injected
in vivo with oxytetracycline and analysed by LC-MS/MS. The qualitative positive (+)/negative (−)
result is also shown in the table. Cut-off = 55.
Sample LC-MS/MS (µg Kg−1) e-Reader® Value Qualitative Result
1 403 94 +
2 <10 40 −
3 375 87 +
4 234 70 +
5 220 86 +
6 71 57 +
7 83 53 −
8 89 50 −
9 46 52 −
10 24 33 −
11 37 35 −
12 102 57 +
13 55 48 −
14 41 50 −
15 32 32 −
16 58 34 −
Table 5. Explorer®-Blood test coupled to e-Reader® values obtained for blood serum samples
injected in vivo with sulfamethoxypyridazine and analysed by LC-MS/MS. The qualitative positive
(+)/negative (−) result is also shown in the table. Cut-off = 55.
Sample LC-MS/MS (µg Kg−1) e-Reader® Value Qualitative Result
1 1095 115 +
2 133 94 +
3 51 74 +
4 11 35 −
5 4098 117 +
6 773 112 +
7 569 114 +
8 115 89 +
9 25 102 +
10 3462 111 +
11 1113 109 +
12 229 101 +
13 74 82 +
14 35 65 +
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Overall, and thanks to the described procedure (Figure 5) and the validation carried
out, Explorer®-Blood is proposed as a new, accurate tool for the in vivo detection of
antibacterial residues, useful in preventing non-compliant animals from being delivered to
slaughterhouses and thus avoiding their entrance into the food chain.
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4. Conclusions
A post mortem method for the screening of antimicrobials in meat has been adapted
as an ante mortem tool for the analysis of antibiotics and sulfonamides in blood serum.
The new method was validated and compared with results obtained in meat, thereby
proving that the Explorer®-Blood test coupled to e-Reader® is a suitable method for ante
mortem i plementation at farm or slaughterhouse level. On the one hand, blood serum
proved to be the ideal matrix, as it is easy to obtain and prepare for analysis and its
antimicrobial concentrations showed a satisfactory equivalence with muscle in the case of
most antimicrobials [25]. On the other hand, this method’s adaptation only required a small
number of modifications, thereby maintaining its ease of analysis. The new Explorer®-
Blood test can be carried out by non-qualified personnel, at any location, and within a brief
time interval. Hence, it can be regarded as a pioneering tool for the analysis of antibacterial
residues in living animals, thereby ensuring the absence of such residues in meat while
preserving the agricultural production economy as well as consumer health.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/foods10081897/s1, Table S1: e-Reader® values obtained with Explorer®-Blood for the different
combinations of antimicrobials and concentrations tested (spiked samples). Each column (R1-R10)
presents the result of each of the replicates analyzed, as well as de medium value, standard deviation
(SD) and qualitative result (+/−). For comparison purposes and as a reference, the last column
includes the EU-MRLs for muscle (Commission Regulation (EU) No. 37/2010). Concentration is
presented as µg Kg−1. Concentrations in bold correspond to the LoDs of the method.
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